Immunotherapy & Biological Cancer Care in Udaipur
Innovative immune checkpoint inhibitor therapies empowering the patient's own immune system to identify and destroy malignant cells. Managed under the clinical leadership of Dr. Narendra Rathore (Professor & Head of Radiation Oncology) at MB Hospital Campus, RNT Medical College, Udaipur.
Medical Overview & Clinical Background
Immunotherapy represents one of the most groundbreaking advancements in modern oncology. Unlike conventional chemotherapy which directly attacks dividing cells, immunotherapy activates the host immune system—specifically cytotoxic T-lymphocytes—to overcome tumor immune evasion mechanisms and eradicate cancer cells throughout the body.
Understanding the Disease & Treatment Mechanics
Cancer cells frequently express surface proteins such as PD-L1 that bind to PD-1 receptors on immune T-cells, effectively switching off the body's natural anti-tumor defense. Immune Checkpoint Inhibitors (ICIs)—such as Pembrolizumab, Nivolumab, and Atezolizumab—block these inhibitory pathways. Once unmasked, immune T-cells recognize cancer cells as foreign entities and initiate targeted immune-mediated destruction. Dr. Narendra Rathore evaluates specialized biomarker panels—including PD-L1 immunohistochemistry, Microsatellite Instability (MSI-High), and Mismatch Repair (dMMR) status—to determine candidate suitability.
Treatment Approach & Clinical Protocols
Immunotherapy is administered as an outpatient intravenous infusion, typically given every 2 to 4 weeks depending on the specific protocol. Prior to each infusion, comprehensive laboratory monitoring and clinical assessments are conducted. Because immunotherapy works through immune system activation, patients do not suffer standard chemotherapy side effects like hair loss or severe bone marrow suppression.
Common Indications & Applications
- Advanced Non-Small Cell Lung Cancer (NSCLC)
- Recurrent or metastatic Head & Neck Squamous Cell Carcinoma
- Renal Cell Carcinoma (Kidney Cancer) & Urothelial Carcinoma
- Malignant Melanoma & Merkel Cell Carcinoma
- MSI-High or dMMR solid tumors across gastrointestinal malignancies
What Patients Should Expect
Outpatient intravenous infusions lasting 30 to 60 minutes every few weeks. Routine clinical check-ups and periodic scan evaluations (PET-CT or CT) every 8 to 12 weeks to measure treatment response.
Recovery, Side Effect Management & Hygiene
While generally well-tolerated, immune system activation can occasionally lead to immune-related adverse events (irAEs) affecting healthy organs such as the skin (rash), thyroid gland (hypothyroidism), digestive tract (colitis), or lungs (pneumonitis). Early identification is key. Dr. Rathore provides diligent monitoring and immediate management protocols using tailored corticosteroid therapy if immune side effects develop.
Frequently Asked Questions
Q: Does immunotherapy cause hair loss or severe vomiting?
No. Unlike cytotoxic chemotherapy, immunotherapy does not cause hair loss or severe nausea because it does not destroy rapidly dividing non-cancerous hair and mucosal cells.
Q: How do doctors test if my cancer will respond to immunotherapy?
Specialized pathology tests on biopsy tissue—such as PD-L1 staining score, MSI-High testing, and Tumor Mutational Burden (TMB)—predict how likely your cancer is to respond.
Q: What symptoms should I report immediately during immunotherapy?
Report new skin rashes, persistent watery diarrhea, unexplained shortness of breath, severe fatigue, or persistent fever directly to your oncology care team.
Educational Notice:
This information is educational and does not replace an in-person medical consultation. Specific treatment decisions depend on individualized clinical, radiological, and histopathological evaluation during an appointment with Dr. Narendra Rathore at MB Hospital, Udaipur.
Other Cancer Services & Clinical Specialties
Advanced computer-targeted radiation therapy delivering high-precision beams to destroy cancer cells while safeguarding adjacent healthy organs.
Brachytherapy (Internal Radiation)High-dose internal radiation therapy delivering precise treatment directly into or near the tumor, sparing surrounding healthy tissues.
Chemotherapy & Systemic Cancer CareEvidence-based systemic chemotherapy protocols designed to eliminate malignant cells, shrink tumors, and prevent disease recurrence.
Comprehensive Breast Cancer TreatmentMultidisciplinary breast cancer care combining radiation therapy, chemotherapy, targeted HER2 therapy, and hormone receptor management.
Targeted Precision TherapyPrecision medicine targeting specific genetic mutations and molecular pathways driving tumor growth.
Head & Neck Cancer Care & Radiation ManagementSpecialized curative chemoradiation and rehabilitation protocols for cancers of the oral cavity, tongue, larynx, and pharynx.
Regional District Guides (Immunotherapy & Biological Cancer Care in Mewar & Vagad)
Dr. Narendra Rathore provides specialized Immunotherapy & Biological Cancer Care consultation at MB Hospital, Udaipur for patients visiting from across 10 districts in Southern Rajasthan:
Have Questions About Immunotherapy & Biological Cancer Care?
Chat 24/7 with Dr. Narendra Rathore's OncoAssist AI Companion to get instant, accurate information on Immunotherapy & Biological Cancer Care procedures, preparation, side-effect care, and consultation steps. Trained on patient FAQs, radiation therapy protocols, chemotherapy precautions, and OPD appointment logistics.
Dr. Narendra Rathore
MBBS, MD (Radiotherapy)Professor and Head of Department, Radiation Oncology
RNT Medical College, Udaipur, Udaipur, Rajasthan
Senior Radiation Oncologist with over 15+ years of specialized clinical experience leading high-precision radiation therapy (3D-CRT/IMRT), systemic chemotherapy, and targeted cancer management at RNT Medical College & MB Hospital, Udaipur. Dedicated to evidence-based, compassionate cancer care across Southern Rajasthan.
Schedule Your OPD Consultation
All oncology consultations, scan reviews, and treatment planning with Dr. Narendra Rathore are conducted strictly in-person at MB Hospital campus, Udaipur.
- Original Biopsy & Histopathology Reports
- CT / MRI / PET Scan Films & DICOM CDs
- Prior Doctor Prescriptions & Chemotherapy Records
- Patient Photo ID & Scheme Card (RGHS / Chiranjeevi)